Investment firm Leerink Partners has recently increased their Q2 2023 earnings per share forecast for Agilon Health ($NYSE:AGL), Inc. Agilon Health, Inc. is a healthcare technology company that provides innovative technology solutions to its customers in the health care industry. It offers a comprehensive suite of integrated software, data and analytics products that enable healthcare organizations to achieve greater operational efficiency and clinical outcomes. The company is headquartered in Redwood City, California and has offices across the United States. Their products are designed to help healthcare organizations reduce costs, improve quality of care, and increase patient satisfaction. By leveraging real-time data, predictive analytics, and machine learning, Agilon Health’s products provide healthcare organizations with actionable insights to make informed decisions and optimize operations.
Agilon Health also provides comprehensive consulting services to help customers implement their solutions and maximize the return on their investment. With a rapidly growing customer base, Agilon Health is uniquely positioned to help healthcare organizations transition from legacy systems to more advanced technology solutions. The company is rapidly expanding its reach in the healthcare industry and is well-positioned to benefit from the increasing demand for innovative technology solutions.
Leerink Partners recently released a report noting an increase in their estimates of earnings per share for Agilon Health, Inc for the second quarter of FY2023. According to the earnings report for the second quarter of FY2023, as of June 30, 2021, Agilon Health, Inc had total revenue of 498.96M USD and a net loss of 298.85M USD. This marks a 25.5% decrease in total revenue compared to the previous year. However, Agilon Health’s total revenue has increased over the last three years from 498.96M USD to 1149.05M USD.
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Agilon Health. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Agilon Health. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Agilon Health. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Agilon Health are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
This shift in estimate reflects the growing confidence in Agilon Health‘s operations and their ability to meet their Q2 2023 earnings targets. Live Quote…
At GoodWhale, we have conducted an analysis of AGILON HEALTH‘s fundamentals and found that it is a medium risk investment in terms of financial and business aspects. We have detected 3 risk warnings in their income sheet, cashflow statement, and financial journal. Therefore, we recommend that potential investors become a registered user to review the data and make their own informed decisions. We believe that our research and data can be a useful resource for investors looking to assess the risk of investing in AGILON HEALTH. More…
Risk Rating Analysis
Star Chart Analysis
Its competitors include P3 Health Partners Inc, Oak Street Health Inc, and Pathway Health Corp.
– P3 Health Partners Inc ($NASDAQ:PIII)
P3 Health Partners Inc is a US-based healthcare company that provides services and products to health plans, provider groups, and individuals. The company has a market capitalization of 212.47 million as of 2022 and a return on equity of 196.33%. P3 Health Partners Inc is a leading provider of healthcare services and products in the United States. The company offers a wide range of services and products, including health insurance, provider services, and individual products. P3 Health Partners Inc is a publicly traded company listed on the New York Stock Exchange.
– Oak Street Health Inc ($NYSE:OSH)
Oak Street Health Inc is a healthcare services company that operates primary care centers for adults on Medicare in the United States. As of December 31, 2020, the company operated 109 primary care centers in Illinois, Indiana, Michigan, New Jersey, Pennsylvania, and Rhode Island. The company was founded in 2013 and is headquartered in Chicago, Illinois.
– Pathway Health Corp ($TSXV:PHC)
Pathway Health Corp has a market cap of 4.69M as of 2022, a Return on Equity of -239.69%. The company provides healthcare services to skilled nursing and assisted living facilities.
Investment analysts at Leerink Partners recently increased their earnings-per-share estimates for AGILON Health‘s second quarter of 2023. In response to the news, the company’s stock saw a positive movement on the same day. Investing analysis on AGILON Health indicates that shareholders should consider it a favorable development, given that higher earnings per share often leads to improved stock prices. When evaluating AGILON Health, investors should consider the company’s financials, including its income statement and balance sheet, as well as its competitive advantages and pricing strategy.
Additionally, investors should consider other factors such as industry trends and market conditions when making investment decisions.